2020 Leadership Journey Project: Increasing Gender Equity and Integration into VD&S and EDD grantmaking
Vivian Hsu has been at the Bill & Melinda Gates Foundation since 2016 and is currently the Deputy Director of Strategy, Planning and Management for the Vaccine Development and Surveillance and Enteric and Diarrheal Diseases teams. In this capacity, she manages the strategy and business operations for the teams whose core focus is investments in Enteric Disease vaccines and surveillance, new vaccine manufacturing technologies, infectious disease surveillance, epidemic preparedness and control, HPV and Polio product development, and other vaccine development innovations. Her portfolio of work spans the spectrum of driving day-to-day business management to leading major cross-foundation initiatives. Currently, she is also coordinating the Gates Foundation COVID-19 vaccine development efforts and supporting the foundation-wide COVID-19 response.
Vivian’s career has centered around the healthcare industry, beginning as a consultant in the US pharmaceutical industry prior to moving to Hong Kong to join McKinsey and Company. There, she spent the majority of her three years developing China market strategies for various multinational pharmaceutical and hospital corporations. In 2013, Vivian joined Evolent Health, a population health services company. With her team, she built Evolent’s payer partnership practice which partnered with hospitals to design value-based care infrastructure and negotiate population-based contracts with private insurance companies, Medicare and state Medicaid agencies.
Vivian graduated from Yale University in 2006 with a degree in political science and East Asian studies and from Wharton School of Business at the University of Pennsylvania with a Masters in Business Administration in Healthcare Management.
